Capital World Investors, a registered investment adviser, initiated a new position in CVS Health Corporation (NYSE:CVS) during Q4 2025, according to its most recent 13F filing…
Capital World Investors, a registered investment adviser, initiated a new position in CVS Health Corporation (NYSE:CVS) during Q4 2025, according to its most recent 13F filing with the Securities and Exchange Commission.
The institutional investor purchased 67,662,911 shares of the Healthcare company, valued at approximately $5.4B as of the filing date.
CVS Health Corporation's stock currently trades at $77.48 with a market capitalization of $102.6B.
Current market data
NYSE · CVS
$88.84
Down: -$1.43 · -1.58%
Live quote updated
Our Markets Team monitors market data, SEC filings, analyst actions, earnings releases, and corporate announcements to produce timely updates for investors.
Keep reading
analyst ·
institutional ·
institutional ·
analyst ·
